^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IO-108

    i
    Other names: IO-108, LILRB2 Antibody
    Associations
    News
    Trials
    Company:
    Immune-Onc Therap
    Drug class:
    ILT-4 inhibitor
    Related drugs:
    Associations
    News
    Trials